Skip to content

Home Outpatient Monitoring and Engagement to Predict HF Exacerbation

Home Outpatient Monitoring and Engagement to Predict HF Exacerbation (HOME PREDICT-HF)

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03479424
Acronym
Home Predict
Enrollment
30
Registered
2018-03-27
Start date
2018-10-08
Completion date
2019-03-01
Last updated
2019-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Failure With Reduced Ejection Fraction

Keywords

hospitalization

Brief summary

The HOME PREDICT HF study looks at new ways to predict hospitalizations for heart failure. We will use a set of devices at home and surveys to collect information about patient's health. This study uses the Eureka app, a new study app developed by the University of California, San Francisco. The study is designed to happen remotely, using this application on a patient's smartphone, so that is as convenient as possible to participate.

Detailed description

HOME PREDICT HF is single center, prospective, unblinded, randomly assigned training and validation observational cohorts to develop machine learning algorithms from an in-home suite of sensors in order to predict 3-month heart failure hospitalization and/or emergency department visits. Study population includes adults presenting with a diagnosis of reduced ejection fraction (LVEF \<= 40%), NYHA class II-IV) who have had a hospitalization for HF in the previous 6 months. The study objectives include (1) To collect observational data from multiple sensors, patient-reported outcomes, and medical record data to develop (train) machine-learning algorithms (2) To validate trained algorithms in a separate validation cohort (3) To collect data to inform the design of a future intervention study. The primary outcome is Ninety-day heart failure hospitalization/emergency department visit for heart failure.

Interventions

OTHERObservational

The MYIA in-home suite of devices.

Sponsors

MYIA Labs, Inc.
CollaboratorUNKNOWN
University of California, San Francisco
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Outpatient and cared for by a PINNACLE Registry practice 2. Age ≥ 18 years old 3. Has a diagnosis of HF in the PINNACLE Registry/Medical Record 4. Seen by PINNACLE practice within the last 12 months 5. Has an LVEF ≤40% on their last data entry (within 1 year) in the PINNACLE Registry 6. NYHA Class II-IV by self-report 7. Has had a hospitalization for HF in the previous 6 months by self-report 8. Owns an Android or iOS smartphone, within Verizon cellular coverage zone in order to allow for data submission. 9. Sleep in the same bed at least 5 days per week 10. Willingness to complete the required surveys, measurements and study activities.

Exclusion criteria

1. Home oxygen use 2. Current or planned ventricular assist device 3. Previously or currently on a heart transplant list 4. Chronic dialysis 5. A diagnosis of any cancer and undergoing active treatment 6. In hospice or palliative care 7. Planned surgery/procedure in the next 3 months 8. Planned extended time away from home (\>2 weeks) in the next 3 months 9. Living in a skilled nursing facility or other chronic care facility 10. Pregnancy or planned pregnancy in the next 3 months 11. Inability or unwillingness to consent and/or follow requirements of the study

Design outcomes

Primary

MeasureTime frameDescription
Heart Failure Hospitalization/ ED Visit90 dayNinety-day heart failure hospitalization/emergency department visit for heart failure.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026